Arsenic Speciation in Urine from Acute Promyelocytic Leukemia Patients undergoing Arsenic Trioxide Treatment
- 20 December 2003
- journal article
- clinical trial
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 17 (1) , 95-103
- https://doi.org/10.1021/tx0341714
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot reportBlood, 2002
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- DMPS–Arsenic Challenge TestToxicology and Applied Pharmacology, 2000
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITYAnnual Review of Pharmacology and Toxicology, 1997
- Comparative Inhibition of Yeast Glutathione Reductase by Arsenicals and ArsenothiolsChemical Research in Toxicology, 1997
- Arsenic speciation in the environmentChemical Reviews, 1989
- Biological Methylation.Chemical Reviews, 1945
- CXLIX.—A new type of compound containing arsenicJournal of the Chemical Society, Transactions, 1920